Rezension:
Looking for work family fare pharmacy generics The battle has turned into a rout, at least for now. In state after state, the brand-name makersâ??led by the pharmaceutical giants Amgen and Genentechâ??have been unable to convince state legislatures to require pharmacists to notify doctors (and sometimes patients) when they substitute generics for brand-name biologic drugs. Manufacturers of copies fiercely opposed such a requirement, which they said would put them at a competitive disadvantage.
